MRC1 and colorectal carcinoma: In contrast to the MMR gene mutations of the LS, the study reveals for the first time at the population level that carriers of germline mutations in the HR pathway genes are significantly susceptible to CRC, implicating HR pathway gene mutations as another major contributor for increased risk of developing CRC.